5 Results for "

CDK-2:CyclinA

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "CDK-2:CyclinA" in MCE Product Catalog:

Cat. No.: HY-15569
CAS No.: 444722-95-6
Purity:  99.23%
Target:  

CDK

Research Areas:  

Cancer

NU6102 is a potent CDK1 and CDK2 inhibitor with IC50s of 9.5 nM and 5.4 nM for CDK1/cyclinB and CDK2/cyclinA3, respectively. NU6102 shows selectivity for CDK1/CDK2 over CDK4 (IC50 of 1.6 μM), DYRK1A (IC50 of 0.9 μM), PDK1 (IC50 of 0.8 μM) and ROCKII (IC50 of 0.6 μM) [2].
loading...
    loading...
Cat. No.: HY-120497
CAS No.: 1132609-87-0
Purity:  98.11%
Target:  

PKC CDK

Research Areas:  

Inflammation/Immunology

PKCζ-IN-1 is a PKCζ-selective inhibitor with an IC50 of 5.18 nM against human PKCζ. PKCζ-IN-1 also inhibits CDK2 with an IC50 of 1.04 μM. PKCζ-IN-1 is applicable to research related to immune and inflammatory diseases .
loading...
    loading...
Cat. No.: HY-P10680
Target:  

Liposome

Research Areas:  

Others

TFE-IDAtp1-LinA is a highly potent amphiphilic carrier, containing a trifluoroethyl-iminodiacetic acid analog of Stp. TFE-IDAtp1-LinA, formed nanoparticles with Cas9 RNP/ssDNA, achieved enhanced green fluorescent protein knockouts with an ED50 of 0.38 nM Cas9/sgRNA ribonucleoproteins (RNP) .
loading...
    loading...
Cat. No.: HY-123238
CAS No.: 750575-23-6
Target:  

CDK

Research Areas:  

Cancer

AG-024104 is a CDK inhibitor with Ki values of 2.3 nM (CDK1/cyclinB), 1.8 nM (CDK2/cyclinA), and 0.67 nM (CDK4/cyclinD). AG-024104 functionally inhibits kinase activity of CDK1/cyclinB, CDK2/cyclinA, and CDK4/cyclinD. AG-024104 serves as a negative control for peripheral leukocyte toxicity studies in preclinical development .
loading...
    loading...
Cat. No.: HY-155180
CAS No.: 2685870-87-3
Target:  

PI3K

Research Areas:  

Cancer

FD2056 is a potent and orally active PI3K inhibitor. FD2056 inhibits PI3Kα/PI3Kβ/PI3Kγ/PI3Kδ with IC50s of 0.30, 0.80, 1.10, 0.42 nM. FD2056 also inhibits CDK2-CyclinA2 and CDK4-CyclinD3 with IC50 of 115.95 and 2782.15 nM. FD2056 inhibits breast cancer cell proliferation with IC50s of 1.06, 0.04, 1.40 μM for MDA-MB-231, MDA-MB-468, MCF-7 cells. FD2056 also induces cancer apoptosis and inhibits tumor growth .
loading...
    loading...